Skip to content
Research Article Open access CC BY 4.0

Improved Efficacy of Cotrimoxazole with Medicinal Synthetic Aluminum-Magnesium Silicate for Effective Treatment of Trypanosomosis

Akpan, Clara Amaka Nkpoikanke, Ezeibe, Maduike Chiehiura Onwubuko, Sanda, Mary Ekundayo, Okey, Stephen Nnaemeka, Ogbonna, Ijeoma Joy, Ezeibe, Favour Ijeoma

Asian Journal of Research in Animal and Veterinary Sciences · pp. 472–482 · Published 13 Dec 2023

10.9734/ajravs/2023/v6i4275

Abstract

Aims: The mechanism of Cotrimoxazole (Sulfamethoxazole and Trimethoprim combination) as an anti-bacterial drug is inhibition of Folic Acid but its anti-trypanocidal efficacy has not been investigated though Trypanosomes also require Folic Acid for replication. Development of resistance by Trypanosomes against drugs, frequent relapse infections and toxicity of most trypanocides demand that the search for new Trypanocidal drugs be continuous. Aluminum magnesium silicate (AMS) and its formulation named Medicinal Synthetic AMS (MSAMS) have been reported to stabilize other medicines. Stabilizing medicines improves the length of time they remain at high bioavailability and when drugs remain at high concentration in plasma for a long time, their efficacies improve. Improving the anti-folic acid efficacy of Cotrimoxazole may deny Trypanosomes Folic Acid to the extent that their replication could be inhibited. Study Design: Fifteen West African Dwarf (WAD) sheep allotted to 3 groups of 5 animals each were used. One group was infected and treated, the second group was infected and untreated while the third group was uninfected and untreated. Place and Duration of Study: the study was conducted in the Department of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike/ for a period of 7 months. Methodology: Five (5) Trypanosoma b. brucei infected sheep (WAD) were treated with Cotrimoxazole MSAMS formulation at dose of 120mg/kg orally for 5 days while another group was left untreated. Results: Mean parasitaemia of 80.49±7.56 million parasite per ml of blood was recorded just before commencement of the treatment but nine days after treatment with the Cotrimoxazole-MSAMS formulation the parasitaemia of the treated group reduced (P≤ 0.05) from 2.25±1.50 in the control to 0.00± 0.00). Cotrimoxazole-MSAMS terminated parasitaemia in Trypanosoma b. brucei infected WAD sheep 9 days post-treatment. Relapse infection was not observed up to 100 days post-treatment. Conclusion: MSAMS enhanced the anti-folic acid efficacy of Cotrimoxazole so that it cleared Trypanosome parasitaemia and there was no relapse.

Efficacy cotrimoxazole medicinal synthetic aluminum magnesium silicate trypanosomosis West African Dwarf Sheep

References (41)

  1. 1 The American Journal of Tropical Medicine and Hygiene [DOI]
  2. 2 Path Analysis: Sociological Examples [DOI]
  3. 3 International Journal for Parasitology [DOI]
  4. 4 Clinical Microbiology and Infection [DOI]
  5. 5 An improved parasitological technique for the diagnosis of African trypanosomiasis [DOI]
  6. 6 Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions [DOI]
  7. 7 The animal trypanosomiases and their chemotherapy: a review [DOI]
  8. 8 Trimethoprim-Sulfamethoxazole Revisited [DOI]
  9. 9 Molecular and biochemical parasitology [DOI]
  10. 10 Aspect Ratio Determines the Quantity of Mesoporous Silica Nanoparticle Uptake by a Small GTPase-Dependent Macropinocytosis Mechanism [DOI]
  11. 11 The Office International des Epizooties [DOI]
  12. 12 Antigenic variation in African trypanosomes [DOI]
  13. 13 Human African trypanosomiasis: pharmacological re‐engagement with a neglected disease [DOI]
  14. 14 Transporters in African trypanosomes: role in drug action and resistance [DOI]
  15. 15 Development of a mathematical model for mechanical transmission of trypanosomes and other pathogens of cattle transmitted by tabanids [DOI]
  16. 16 What Do We Really Know About Antibiotic Pharmacodynamics? [DOI]
  17. 17 Cotrimoxazole for Treatment of Cerebral Toxoplasmosis: An Observational Cohort Study during 1994–2006 [DOI]
  18. 18 Cattle trypanosomosis: the diversity of trypanosomes and implications for disease epidemiology and control [DOI]
  19. 19 Early Invasion of Brain Parenchyma by African Trypanosomes [DOI]
  20. 20 Contemporary unconventional clinical use of co-trimoxazole [DOI]
  21. 21 An atlas of tsetse and bovine trypanosomosis in Sudan [DOI]
  22. 22 Evaluation of medicinal plants from Mali for their in vitro and in vivo trypanocidal activity [DOI]
  23. 23 Cost analysis of options for management of African Animal Trypanosomiasis using interventions targeted at cattle in Tororo District; south-eastern Uganda [DOI]
  24. 24 Cure of Acanthamoeba cerebral abscess in a liver transplant patient [DOI]
  25. 25 Trimethoprim Resistance of Dihydrofolate Reductase Variants from Clinical Isolates of Pneumocystis jirovecii [DOI]
  26. 26 Haematological and biochemical changes in experimental Trypanosoma evansi infection in rabbits [DOI]
  27. 27 Variant Surface Glycoprotein gene repertoires in Trypanosoma brucei have diverged to become strain-specific [DOI]
  28. 28 An improved parasitological technique for the diagnosis of African trypanosomiasis? [DOI]
  29. 29 The Federal Republic of Nigeria [DOI]
  30. 30 In vivo experimental drug resistance study in Trypanosoma vivax isolates from tsetse infested and non-tsetse infested areas of Northwest Ethiopia [DOI]
  31. 31 Changes in haematological indices and protein concentrations in Trypanosoma brucei infected rats treated with homidium chloride and diminazene aceturate.
  32. 32 Treatment of toxoplasmic lymphadenitis with co-trimoxazole: double-blind, randomized clinical trial [DOI]
  33. 33 Study on the mechanical transmission by tsetse fly Glossina morsitans centralis of Trypanosoma vivax , T. congolense or T. brucei brucei to goats [DOI]
  34. 34 Pharmacokinetics and bioavailability of trimethoprim‐sulfamethoxazole in alpacas [DOI]
  35. 35 Clinical and Hematological Profiles of Malaysian Ponies Experimentally Infected with a Field Strain of Trypanosoma evansi [DOI]
  36. 36 Hormonal Control of Gut Motility in Ruminants and Non-Ruminants and Its Nutritional Implications [DOI]
  37. 37 Pharmacokinetics of sulphadoxine and trimethoprim and tissue irritation caused by two sulphadoxine-trimethoprim containing products after subcutaneous administration in pre-ruminant calves [DOI]
  38. 38 Effects of Prolonged Treatment With Co-trimoxazole on the Thyroid Gland, Liver, and Epididymal Sperm Reserve in Dogs [DOI]
  39. 39 Antigenic variation in African trypanosomes and malaria [DOI]
  40. 40 Effects of Trypanosoma brucei infection and treatment on haematoserological response of West African Dwarf sheep to Brucella abortus vaccine [DOI]
  41. 41 Cotrimoxazole, clinical uses and malaria chemotherapy.

Cited by 2

In vitro inhibitory effects of gentamicin and ceftiofur against Trypanosoma evansi: Promising antibiotic alternatives for equine trypanosomosis in Thailand

Apiraya Rudeekiatthamrong, Giang Thi Nguyen, K. Kamyingkird · Veterinary World · 2025

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

29

Page views

0

PDF downloads

2

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.